SCHEMBL7575874

SCHEMBL7575874

CCN(C(N)=O)c1ccc(O)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.47
GLA P06280 1/20 0.47
TSHR P16473 1/20 0.47
ESR1 P03372 4/20 0.44
ESR2 Q92731 2/20 0.44
CA2 P00918 2/20 0.41
CYP3A4 P08684 1/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
ESRRG P62508 2/20 0.39
LMNA P02545 1/20 0.39
POLB P06746 1/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
ESRRB O95718 1/20 0.39
HSD17B3 P37058 1/20 0.38
MLYCD O95822 2/20 0.38
ADRA2A P08913 1/20 0.38
ADRA2B P18089 1/20 0.38
ADRA2C P18825 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL657891 0.84 ALDH1A1 (0.52) ALDH1A1GLATSHRCYP3A4MEN1
SCHEMBL18840276 0.83 ALDH1A1 (0.67) ALDH1A1GLATSHRESR1ESR2
SCHEMBL27544700 0.82 ALDH1A1 (0.46) ALDH1A1GLATSHRCYP3A4MEN1
SCHEMBL27508524 0.82 CYP3A4 (0.58) ALDH1A1GLATSHRCYP3A4GAA
SCHEMBL340272 0.82 ALDH1A1 (0.70) ALDH1A1GLATSHRCYP3A4MEN1
SCHEMBL5702149 0.82 ALDH1A1 (0.53) ALDH1A1GLATSHRESR1ESR2
SCHEMBL10926482 0.82 ALDH1A1 (0.48) ALDH1A1GLATSHRESR1ESR2
SCHEMBL6421500 0.82 ALDH1A1 (0.48) ALDH1A1GLATSHRESR1ESR2
Hydrochloric Acid SCHEMBL28795770 0.81 ALDH1A1 (0.44) ALDH1A1GLATSHRCYP3A4GAA
Hydrochloric Acid SCHEMBL10801383 0.81 ALDH1A1 (0.48) ALDH1A1GLATSHRCYP3A4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6451814-B1 SUBSTITUTED 4-((4-AMINO-5-HYDROXYPHENYL)-OXY-)PIPERIDINE ANALOGS; METABOLIC DISORDERS; ANTIDIABETIC AGENTS; ATHERO-SCLEROSIS, GASTROINTESTINAL DISORDERS, GLAUCOMA, NEUROGENETIC INFLAMMATION, OCULAR HYPERTENSION AND FREQUENT URINATION WYETH 2002-09-17 US disclosed
US-20020028832-A1 Heterocyclic beta-3 adrenergic receptor agonists AMERICAN HOME PRODUCTS CORPORATION (US) 2002-03-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020028832-A1 Heterocyclic beta-3 adrenergic receptor agonists ADRB1, ADRB3, ADRB2 ALDH1A1 524/4885GLA 879/4885TSHR 552/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.